npj Precision Oncology Impact Factor, Quartile, Indexing, Ranking

npj Precision Oncology Impact Factor, Indexing, Ranking

npj Precision Oncology (nPO) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Springer. and its abbreviation is NPJ Precis Oncol.


npj Precision Oncology Aim and Scope

npj Precision Oncology is an international, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications to clinical medicine.
The journal defines precision oncology as cancer diagnosis, prognosis, prevention and/or treatment tailored specifically to the individual patient based on the genetic and/or molecular profile of the patient. High-impact articles that entail relevant studies using panomics, molecular, cellular and/or targeted approaches in the cancer research field are considered for publication. All areas of precision oncology from basic research to clinical applications will be considered.
Featured topics include carcinogenesis, targeted immunotherapy, mechanism-based therapies targeting specific cellular signaling pathways, genetic risk factors, miRNAs, tumor microenvironment, cancer metabolism and cancer stem cells – all in the context of diagnosis/prognosis/therapy, drug resistance mechanisms, reoccurrence,  intervention strategies, emerging clinical and translational aspects.


npj Precision Oncology Details


Journal title npj Precision Oncology (nPO)
Abbreviation NPJ Precis Oncol
Online ISSN 2397-768X
Publisher Name Springer
Editor-in-chief Trever Bivona, MD, PhD
Subject Category Medicine
Access type Logo of open access journals Open Access
Impact Factor 9.0
SJR 2.520
SNIP 1.415
Ranking 728
CiteScore 9.6
H-Index 30
Quartile Q1
Article Publication Charges (APC) 2690 GBP, 3490 USD, 2990 EUR

✳️Without APC Medicine Journals
Review Time 197 days
Status 🟢 Active
Abstracting and Indexing
Impact Factor List 2024

Who we are? Clarification: Journals Insights - Your Open Access Ally
F T L W E